期刊文献+

韧带样型纤维瘤病的超声表现及病理特征研究 被引量:5

Ultrasonic manifestations and pathological features of desmoid-type fibromatosis
下载PDF
导出
摘要 目的探讨韧带样型纤维瘤病(DF)的超声特征及病理特征。方法回顾分析38例经病理证实为DF的病例,分析其超声特征与病理表现。结果 38例DF中腹壁外型22例、腹壁型11例及腹内型5例。超声主要表现为沿肌纤维浸润性生长的低回声肿块,均未见坏死出血和囊性变灶;病理特征表现为无包膜,呈浸润性生长,来源于纤维母细胞和肌纤维母细胞,瘤细胞无明显异型性,无明显病理性核分裂象。结论超声对DF的诊断及鉴别诊断有一定帮助,但最终确诊仍需依靠病理检查。 Objective To explore the ultrasonic manifestations and pathological features of(desmoid-type fibromatosis,DF). Methods We retrospectively investigated 38 DF were histologically and pathologically proven,and then the sonographic images about lesion location,size,echotexture and vascularity were investigated. Results Thirty-eight lesions were detected,of which 22 were located in extra-abdominal,11 were in abdominal wall muscles,5 were in intra-abdominal. Typical sonographic features of DF were spindle-or oval-shaped,hypo echoic texture,aggressively growing,none of them had cystic,hemorrhagic or necrosis change. The pathological features of DF includes:no tissue infiltration,no obvious capsule or boundary,tumor cell consist of fibroblasts and myofibroblasts,and rare in pathological mitotic figure. Conclusion Although ultrasonic manifestations is helpful for diagnosis and differential diagnosis of DF,pathological diagnosis is accurate.
出处 《临床超声医学杂志》 2015年第11期751-754,共4页 Journal of Clinical Ultrasound in Medicine
关键词 超声检查 韧带样型纤维瘤病 病理诊断 Ultrasonography Desmoid-type fibromatosis Pathological diagnosis
  • 相关文献

参考文献13

  • 1Wu C, Amini - Nik S, Nadesan P, et al. Aggressive fibromatosis (desmoid tumor) is derived from mesenchymal progenitor cells.Cancer Res, 2010,70( 19),7090-7698.
  • 2Fletche CD, Unni KK, Mertens F. World Health Organization classification of tumors: pathology and genetics of tumors of soft tissue and bone.Lyon: IARC Press,2002: 83-84.
  • 3Schiessling S, Kihm M, Ganschow P, et ~.Desmoid tumour biology in patients with familial adenomatous polyposis coli.Br J Surg,2013, 100(5 ) :694-703.
  • 4Miguemi NA, hani DM, Fasig JH, et ',d.Signal transduction pathway analysis in desmoid-type fibromatosis:transforming growth factor-J3, COX2 and sex steroid receptors.Cancer Sci,2012,103 (12): 2173-2180.
  • 5Sturt N J, Clark SK.Current ideas in desmoid tumors.Familial Cancer, 2006,5 ( 3 ) : 275-285.
  • 6Guan SP, Knng LR, Cheng C, et ',d.Protective role of 14-deoxy-11, 12- didehydroandrographolide,a noneytotoxic analogue of andrographolide, in allergic airway inflammation.J Nat Prod, 2011,74( 6 ): 1484-1490.
  • 7Janinis J, Patriki M, Vini L, et al.The pharmacological treatment of aggressive fibromatosis :a systematic review.Ann One01.2003,14 ( 2 ) : 181-190.
  • 8Dempke W, Rie C,Grothey A.Cyc, looxygenase-2: a novel target for cancer chemotherapy.Cancer Res Clin One01,2001,127 (7) :411-417.
  • 9Mccarville MB, Hoffer FA, Adelman CS, et aI.MR1 and biologic behavior of desmoid tumors in children.MR, 2007,189( 3 ) : 663.
  • 10Bhattacharya B, Dilworth HP, laeobuzio-Donahue C, et al.Muclear beta-catenin expression distinguishes deep fibromatosis from other benign and malignant fibroblastic and myofibroblastic lesions.Am J Surg Pathol, 2005,29(5 ) : 653-659.

同被引文献30

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部